|
       |
About Us . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
Our mission is to advance the treatment of chronic neurodegenerative diseases through a novel, multi-target approach to reducing pathologic deposits misfolded proteins. This approach has the potential to slow or prevent the progression of Alzheimer‘s, Parkinson‘s, and other degenerative diseases. |